EFFICIENCY OF THE LOW-DOSE FORMS ESTROGEN-GESTAGEN DRUG TREATMENTTO WOMEN WITH COMPENSATED HYPOTHERIOSIS AND EUTHYROIDISM


如何引用文章

全文:

详细

The article presents research results of 61 perimenopausal and postmenopausal women with diffuse nodular nontoxic goiter and autoimmune thyroiditis, who in the 12 months received treatment low-dose combined estrogen-progestin drug, which includes a 1 mg 17-β estradiol and 2 mg drospirenone. The effect of hormone replacement therapy on coagulation and platelet hemostasis, lipid profile, pituitary-ovarian system, thyroid status were studied. Using of low-dose estrogen-progestin therapy does not worsen diffuse nodular nontoxic goiter and autoimmune thyroiditis flow, does not change the dose of thyroid medications and may be recommended for the treatment of menopausal symptoms in women with thyroid disease.

作者简介

V Gromova

North-Western State Medical University named after I.I. Mechnikov

N Vorokhobina

North-Western State Medical University named after I.I. Mechnikov

O Malygina

North-Western State Medical University named after I.I. Mechnikov

A Kuznetsova

North-Western State Medical University named after I.I. Mechnikov

参考

  1. Медицина климактерия / Под ред. В.П. Сметник - М.: Изд-во «Литера», 2009. - С.848.
  2. Калашникова, М.Ф., Кахтурия, Ю.Б., Мельниченко, Г.А. Особенности пери и постменопаузального периода у женщин с эндокринными заболеваниями // Ж. Проблемы репродукции. - 2003. - №1. - С. 44-51
  3. Зайдиева, Я.З. Гормонопрофилактика метаболических нарушений у женщин в перименопаузе: Автореф. дис. … докт. мед. наук. - М., 1997. - С. 36.
  4. Гринева, Е.Н. Дифференциальная диагностика узлового зоба // Матер.II Рос. Тиреоидол. Конгр. - М., 2002. - С.99.
  5. Hollowell, J., Staehling, N.W., Flanders, W.D. et al. Serum, TSH, T(4), and thyroid antibodies in the United States population: National Health and Nutrition Examination Survey ( NHANES III) // J. Clin. Endocrinol. Metab. - 2002. - Vol. 87. - P. 489-499.
  6. Mendelsone, M.E. Hormone replacement therapy and the cardiovascular system 2005 update//In: 12 th World Congress. Human reproduction/ Ed. A.R. Genazzani/ Venice - 2005. - P. 105-104.
  7. Schindler, A.E. Thyroid function and postmenopause. // Gynecological Enocrinology. - 2003. -Vol. 17, № 1 - P. 79-85.
  8. Hulley, S., Furberg, C., Barret-Connor, E. et al. Noncardiovascular disease outcomes during 6,8 years of hormone therapy. Heart and Estrogen/ progestin replacement Study follow-up (HERS II)// JAMA. - 2002. - Vol. 288. №1 - P. 58-66.
  9. Ушкалова, С.Г. Климактерические расстройства у женщин в постменопаузе с гипофункцией щитовидной железы и их гормональная коррекция: Автореферат дис. … канд. мед. наук. - М., 2002. - С. 12-13.
  10. Estrogen promotes growth of human Thyroid tumor cells by different molecular mechanisms / D. Manole [et al.] // J.Clin. Endocrinol. Metab. - 2001. - Vol. 86, N 3. - P. 1072-1077.
  11. Banu, K. S. Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action / K.S. Banu, P. Govindarajulu, M.M. Aruldhas // Endocr. Pathol. - 2001. - Vol. 12, N 3. - P. 315-327.
  12. Candanedo-Gonzalez, F.A. Postmenopause is associated with recurrence of differentiated papillary thyroid carcinoma / F.A. Candanedo-Gonzalez, A. Gamboa-Dominguez // Med. Hypotheses. - 2007. - Vol. 69, N 1. - Р. 209- 213.
  13. Santin, A.P. Role of estrogen in thyroid function and growth regulation / A.P. Santin, T.W. Furlanetto // J. Thyroid Research. - 2011. - 875125. doi: 10.4061/2011/875125.
  14. Вихляева, Е.М. Постменопаузальная терапия. Влияние на связанные с менопаузой симптомы, течение хронических заболеваний и качество жизни/ М.: МЕДпресс-информ, 2008. - С. 58-59. -C. 110-111.
  15. Benecia, H., Ropelato, M.G., Rosales, M., Mesch V., Siseles N., et al. Thyreoid profile modifications during oral hormone replacement therapy in postmenopausal women. Gynecol Endocrinol. - 1998 - Iun. V. 12(3). - P. 179-84. Argentina.
  16. Bissonnette, F., Lussier-Cacan, S., Fugere P., Berube S. Metabolic effect of two hormonal preparations in postmenopausal women. Maturitas. - 1997 Iul. - V. 27(3). - P. 275-84. Canada.
  17. Erel, C.T., Gezer, A., Senturk, L.M., Somunkiran A., Kaleli S., Seyisoglu H. Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results. J. Reprod Med. - 2007. - V.52. - №12. - P. 1079-84.
  18. Utian, W.H., Shoupe, D., Bachmann, G., et al. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril. - 2001. - V. 75. - P. 1065-79.
  19. Riibig, A. Drospirenone: a new cardiovascular- active progestin with antialdosterone and anti-androgenic properties. //Climacteric.-2003.- V. 6. - №3. - 49-54.
  20. Оelkers, W. Drospirenone, a progestogen with antimineralocorticoid properties a short review. // Molec. Cell. Endocrinol. - 2004. - Vol. 2. - P.255-261.
  21. Godsland, IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, an apolipoprotein (a concentration: analysis of studies published from 1974-2000. Fertil Steril - 2001. - Vol. 75(5). - P. 898-915.
  22. Руководство по климактерию/ Под ред. В.И. Кулакова, В.П. Сметник М.: МИА - 2001. - С.685.
  23. Douketis, J.D., Gordon M., Johnston M., et al. The effect of hormone replacement therapy on trombin generation, fibrinolysis inhibition, and resistance to activated protein C, prospective cohort study and review of literature// Tromb. Res. - 2000. - Vol. 99. - P. 25-34.

版权所有 © Gromova V.A., Vorokhobina N.V., Malygina O.F., Kuznetsova A.V., 2015

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

##common.cookie##